Lonza Archives - Express Pharma

Lonza signs manufacturing agreement with Oasmia for ovarian cancer drug

Moderna signs agreement with Lonza for production of new drug substance

Bain Capital, Cinven to acquire Lonza Specialty Ingredients for $4.7 billion

Lonza appoints Pierre-Alain Ruffieux as new CEO

Lonza sets new goal to make Moderna COVID-19 vaccine ingredients

Noga Therapeutics and Lonza to develop Autologous Lentiviral Gene Therapy on the Cocoon Platform

Moderna and Lonza collaborate to manufacture mRNA vaccine against COVID-19

Lonza seeks drug industry veteran as CEO to sharpen pharma focus

Lonza India plans to double its turnover by 2024

Lonza expands its bioconjugation facility in Visp, Switzerland